LifeStance Health (LFST) Shares Outstanding (2020 - 2026)

LifeStance Health (LFST) has reported Shares Outstanding (Entity) for 7 consecutive years, with $387.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Shares Outstanding (Entity) changed 0.26% year-over-year to $387.8 million; the TTM figure through Mar 2026 stood at $387.8 million (changed 0.26% YoY), while the FY2025 annual figure was $388.3 million, up 1.46% from the prior year.
• Shares Outstanding (Entity) was little changed at $387.8 million in Q1 2026 per LFST's latest filing, from $388.3 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $389.1 million in Q2 2025 and bottomed at $367457.0 in Q4 2023.
• Historically, Shares Outstanding (Entity) has averaged $204.5 million across 5 years, with a median of $382.1 million in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) tumbled 99.88% — and 2024, when it surged 104057.77%.
• LifeStance Health's Shares Outstanding (Entity) stood at $375964.0 in 2022, then decreased by 2.26% to $367457.0 in 2023, then soared by 104057.77% to $382.7 million in 2024, then advanced by 1.46% to $388.3 million in 2025, then declined by 0.13% to $387.8 million in 2026.
• Business Quant data shows LFST's Shares Outstanding (Entity) at $387.8 million in Q1 2026, $388.3 million in Q4 2025, and $389.0 million in Q3 2025.